NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 92 filers reported holding NUVALENT INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,907,535 | -39.9% | 64,692 | -40.5% | 0.02% | -40.0% |
| Q1 2024 | $8,159,880 | -12.7% | 108,668 | -14.5% | 0.03% | -23.1% |
| Q4 2023 | $9,349,315 | +112.5% | 127,046 | +32.7% | 0.04% | +50.0% |
| Q3 2023 | $4,400,019 | +29.6% | 95,715 | +18.9% | 0.03% | +36.8% |
| Q2 2023 | $3,395,444 | +90.1% | 80,518 | +17.6% | 0.02% | +58.3% |
| Q1 2023 | $1,786,252 | +24.6% | 68,465 | +42.3% | 0.01% | 0.0% |
| Q4 2022 | $1,433,282 | – | 48,129 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $1,516,519,081 | 25.23% |
| Bain Capital Life Sciences Investors, LLC | 2,697,267 | $204,614,675 | 22.46% |
| Fairmount Funds Management LLC | 1,924,626 | $146,002,128 | 16.50% |
| Paradigm Biocapital Advisors LP | 4,571,678 | $346,807,493 | 13.27% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 465,710 | $35,328,761 | 8.34% |
| COMMODORE CAPITAL LP | 1,487,756 | $112,861,170 | 7.70% |
| Perceptive Advisors | 2,549,077 | $193,372,981 | 4.66% |
| Boxer Capital, LLC | 1,120,192 | $84,977,765 | 4.48% |
| First Turn Management, LLC | 252,276 | $19,137,657 | 3.11% |
| Ikarian Capital, LLC | 151,601 | $11,500,452 | 2.00% |